Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.
No further clinical development is planned for bronchiectasis.
|Description||B305: Long term administration of Bronchitol|
|Sites||Australia, EU, LA, New Zealand, US|
|Description||B301: Pre Registration trial|
|Sites||Australia, New Zealand, UK|
|Description||B201 and B202: Proof of Concept|
|Sites||Australia, New Zealand|
* ClinicalTrials.gov is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the ClinicalTrials.gov website.
*** No further clinical development planned in Bronchiectasis